Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal.Crown Laboratories, Inc., a privately held, global innovative…
- Homepage
- North America
- North America Legal Chronicle
- Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Tagged: 8-28-2024 Adam Gakin Alyssa D’Antonio Amani Taha Andrew Norwich Angela Hagerman Angela Raleigh Anthony Ji Audrey Sokoloff Berit Freeman Brianna Ferrante Chad Davis Christopher Stoj Crown Laboratories, Inc. Daly Brower Demetrius Warrick Edward Lee Eric Jesse Erich Kaletka Geena Caporale Grace Egger Zagorskis Howard Ellin James Shehan Janine Jjingo Jason Kanner Jessica Kriegsfeld Jordan Murray Joshua Kogan Julia Danforth Juliet Anderson Justin Samson Kaitlin Schock Kimberly Lomot Kirkland & Ellis Lea Nehmeh Lilybelle Davis Lowenstein Sandler Manali Joglekar Maria Raptis Mariana del Carmen Fernandez Mark Heinzelmann Marshall Shaffer Matthew Burner Matthew Hintz Megan Monson Mitchell McDonald Monica Ruiz Nicholas Mehler Nicola Perzichilli Paul Giannoglou Philippa Bond Raquel Fox Raquel Smith Resa Schlossberg Revance Therapeutics, Inc. Robert Paradiso Ryne Posey Sam Khan Santino Pelusi Sarah Yang Scott Price Skadden Steven Choi Tala Ismail Theodore Sica Van Whiting
Author: Laura Testa
…